PRASAD REDDY: Open Payments
NPI 1588862262 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,450 in 60 payments from 11 companies in 2025. Trend: 2023 $1,268 · 2024 $1,450 · 2025 $1,450
Food & beverage: $1,239Education: $210
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 19 | $449 |
| Teva Pharmaceuticals USA, Inc. | 18 | $439 |
| Axsome Therapeutics, Inc. | 2 | $159 |
| E.R. Squibb & Sons, L.L.C. | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Neurocrine BioSciences, Inc. | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Collegium Pharmaceutical, Inc. | 2 | $42 |
| Supernus Pharmaceuticals, Inc. | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
Products named: ARISTADA, Auvelity, UZEDY, AUSTEDO XR, COBENFY, INGREZZA, CAPLYTA, Jornay PM.
Industry payments across CA — which companies pay providers there.
